Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated <i>Neisseria gonorrhoeae</i> Microparticle Vaccine Formulation

The emergence of drug-resistant gonorrhea infections worldwide combined with the lack of a vaccine is alarming. We prepared a novel microparticulate (MP) vaccine formulation using whole-cell inactivated <i>Neisseria gonorrhoeae</i> as the vaccine antigen, with Alum and AddaVax™ as vaccin...

Full description

Bibliographic Details
Main Authors: Priyal Bagwe, Lotika Bajaj, Rikhav P. Gala, Martin J. D‘Souza, Susu M. Zughaier
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/7/983
_version_ 1797443307305959424
author Priyal Bagwe
Lotika Bajaj
Rikhav P. Gala
Martin J. D‘Souza
Susu M. Zughaier
author_facet Priyal Bagwe
Lotika Bajaj
Rikhav P. Gala
Martin J. D‘Souza
Susu M. Zughaier
author_sort Priyal Bagwe
collection DOAJ
description The emergence of drug-resistant gonorrhea infections worldwide combined with the lack of a vaccine is alarming. We prepared a novel microparticulate (MP) vaccine formulation using whole-cell inactivated <i>Neisseria gonorrhoeae</i> as the vaccine antigen, with Alum and AddaVax™ as vaccine adjuvants. The adjuvanted vaccine MP formulation was assessed for in vitro immunostimulatory activity, autophagy, and antigen presentation ability. The data shows that the adjuvanted gonococci vaccine MP enhanced autophagy induction in antigen presenting cells (APCs) compared to gonococci vaccine MP without adjuvants, which is important for enhancing antigen presentation. In addition, the adjuvanted vaccine formulation increased the surface expression of antigen presenting molecules MHCI and MHCII as well as co-stimulatory molecules CD40 and CD86 on the surface of dendritic cells. In addition, the gonococci vaccine microparticles at lower doses did not significantly increase the expression of the death receptor CD95 in APCs, which when elevated leads to suboptimal antigen presentation and reduced immune responses. The adjuvanted whole-cell inactivated gonococci microparticle vaccine formulation enhanced antigen uptake, processing, and antigen presentation.
first_indexed 2024-03-09T12:54:06Z
format Article
id doaj.art-a06f7f927d4b42f4b2caf975a3a0814f
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T12:54:06Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-a06f7f927d4b42f4b2caf975a3a0814f2023-11-30T22:02:10ZengMDPI AGVaccines2076-393X2022-06-0110798310.3390/vaccines10070983Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated <i>Neisseria gonorrhoeae</i> Microparticle Vaccine FormulationPriyal Bagwe0Lotika Bajaj1Rikhav P. Gala2Martin J. D‘Souza3Susu M. Zughaier4Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USAVaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USAFraunhofer USA, Center Mid-Atlantic, Biotechnology Division, 9, Innovation Way, Newark, DE 19011, USAVaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USADepartment of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha P.O. Box 2731, QatarThe emergence of drug-resistant gonorrhea infections worldwide combined with the lack of a vaccine is alarming. We prepared a novel microparticulate (MP) vaccine formulation using whole-cell inactivated <i>Neisseria gonorrhoeae</i> as the vaccine antigen, with Alum and AddaVax™ as vaccine adjuvants. The adjuvanted vaccine MP formulation was assessed for in vitro immunostimulatory activity, autophagy, and antigen presentation ability. The data shows that the adjuvanted gonococci vaccine MP enhanced autophagy induction in antigen presenting cells (APCs) compared to gonococci vaccine MP without adjuvants, which is important for enhancing antigen presentation. In addition, the adjuvanted vaccine formulation increased the surface expression of antigen presenting molecules MHCI and MHCII as well as co-stimulatory molecules CD40 and CD86 on the surface of dendritic cells. In addition, the gonococci vaccine microparticles at lower doses did not significantly increase the expression of the death receptor CD95 in APCs, which when elevated leads to suboptimal antigen presentation and reduced immune responses. The adjuvanted whole-cell inactivated gonococci microparticle vaccine formulation enhanced antigen uptake, processing, and antigen presentation.https://www.mdpi.com/2076-393X/10/7/983<i>Neisseria gonorrhoeae</i>microparticlesvaccinesantigen presentationautophagygonorrhea
spellingShingle Priyal Bagwe
Lotika Bajaj
Rikhav P. Gala
Martin J. D‘Souza
Susu M. Zughaier
Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated <i>Neisseria gonorrhoeae</i> Microparticle Vaccine Formulation
Vaccines
<i>Neisseria gonorrhoeae</i>
microparticles
vaccines
antigen presentation
autophagy
gonorrhea
title Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated <i>Neisseria gonorrhoeae</i> Microparticle Vaccine Formulation
title_full Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated <i>Neisseria gonorrhoeae</i> Microparticle Vaccine Formulation
title_fullStr Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated <i>Neisseria gonorrhoeae</i> Microparticle Vaccine Formulation
title_full_unstemmed Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated <i>Neisseria gonorrhoeae</i> Microparticle Vaccine Formulation
title_short Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated <i>Neisseria gonorrhoeae</i> Microparticle Vaccine Formulation
title_sort assessment of in vitro immunostimulatory activity of an adjuvanted whole cell inactivated i neisseria gonorrhoeae i microparticle vaccine formulation
topic <i>Neisseria gonorrhoeae</i>
microparticles
vaccines
antigen presentation
autophagy
gonorrhea
url https://www.mdpi.com/2076-393X/10/7/983
work_keys_str_mv AT priyalbagwe assessmentofinvitroimmunostimulatoryactivityofanadjuvantedwholecellinactivatedineisseriagonorrhoeaeimicroparticlevaccineformulation
AT lotikabajaj assessmentofinvitroimmunostimulatoryactivityofanadjuvantedwholecellinactivatedineisseriagonorrhoeaeimicroparticlevaccineformulation
AT rikhavpgala assessmentofinvitroimmunostimulatoryactivityofanadjuvantedwholecellinactivatedineisseriagonorrhoeaeimicroparticlevaccineformulation
AT martinjdsouza assessmentofinvitroimmunostimulatoryactivityofanadjuvantedwholecellinactivatedineisseriagonorrhoeaeimicroparticlevaccineformulation
AT susumzughaier assessmentofinvitroimmunostimulatoryactivityofanadjuvantedwholecellinactivatedineisseriagonorrhoeaeimicroparticlevaccineformulation